These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37227152)

  • 1. Synthesis, characterization and biological activity of novel copper complexes containing a β-carboline derivative and amino acids.
    Chen BH; Pan ZY; Feng WW; Liu QY; Liu Y; He L
    Dalton Trans; 2023 Jun; 52(23):8040-8050. PubMed ID: 37227152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1
    Cai DH; Chen BH; Liu QY; Le XY; He L
    Dalton Trans; 2022 Nov; 51(43):16574-16586. PubMed ID: 36263706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization, DNA/HSA interactions and in vitro cytotoxic activities of two novel water-soluble copper(II) complexes with 1,3,5-triazine derivative ligand and amino acids.
    Zhang CL; Liu YX; Zhang XM; Chen S; Shen F; Xiong YH; Liu W; Mao ZW; Le XY
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():414-425. PubMed ID: 30033272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis.
    Zhou XQ; Li Y; Zhang DY; Nie Y; Li ZJ; Gu W; Liu X; Tian JL; Yan SP
    Eur J Med Chem; 2016 May; 114():244-56. PubMed ID: 26994692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel water-soluble Cu(II) gluconate complex inhibits cancer cell growth by triggering apoptosis and ferroptosis related mechanisms.
    Cai DH; Liang BF; Chen BH; Liu QY; Pan ZY; Le XY; He L
    J Inorg Biochem; 2023 Sep; 246():112299. PubMed ID: 37354603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, DNA binding, antibacterial and anticancer properties of two novel water-soluble copper(II) complexes containing gluconate.
    Cai DH; Zhang CL; Liu QY; He L; Liu YJ; Xiong YH; Le XY
    Eur J Med Chem; 2021 Mar; 213():113182. PubMed ID: 33486198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, Characterization, DNA/HSA Interactions, and Anticancer Activity of Two Novel Copper(II) Complexes with 4-Chloro-3-Nitrobenzoic Acid Ligand.
    Zeng ZF; Huang QP; Cai JH; Zheng GJ; Huang QC; Liu ZL; Chen ZL; Wei YH
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed-ligand copper(ii) Schiff base complexes: the role of the co-ligand in DNA binding, DNA cleavage, protein binding and cytotoxicity.
    Lian WJ; Wang XT; Xie CZ; Tian H; Song XQ; Pan HT; Qiao X; Xu JY
    Dalton Trans; 2016 May; 45(22):9073-87. PubMed ID: 27163172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity.
    Simunkova M; Lauro P; Jomova K; Hudecova L; Danko M; Alwasel S; Alhazza IM; Rajcaniova S; Kozovska Z; Kucerova L; Moncol J; Svorc L; Valko M
    J Inorg Biochem; 2019 May; 194():97-113. PubMed ID: 30849593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two water-soluble copper(II) complexes: synthesis, characterization, DNA cleavage, protein binding activities and in vitro anticancer activity studies.
    Lu J; Sun Q; Li JL; Jiang L; Gu W; Liu X; Tian JL; Yan SP
    J Inorg Biochem; 2014 Aug; 137():46-56. PubMed ID: 24803026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complexes of copper(II) with tetradentate S,O-ligands: Synthesis, characterization, DNA/albumin interactions, molecular docking simulations and antitumor activity.
    Živanović AS; Bukonjić AM; Jovanović-Stević S; Bogojeski J; Ćoćić D; Bijelić AP; Ratković ZR; Volarević V; Miloradović D; Tomović DL; Radić GP
    J Inorg Biochem; 2022 Aug; 233():111861. PubMed ID: 35599165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two new Cu(II) dipeptide complexes based on 5-methyl-2-(2'-pyridyl)benzimidazole as potential antimicrobial and anticancer drugs: Special exploration of their possible anticancer mechanism.
    Qi YY; Gan Q; Liu YX; Xiong YH; Mao ZW; Le XY
    Eur J Med Chem; 2018 Jun; 154():220-232. PubMed ID: 29803995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological characterization and evaluation of molecular mechanisms of novel copper complexes as anticancer agents.
    Acilan C; Cevatemre B; Adiguzel Z; Karakas D; Ulukaya E; Ribeiro N; Correia I; Pessoa JC
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):218-234. PubMed ID: 27773706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein binding studies with human serum albumin, molecular docking and in vitro cytotoxicity studies using HeLa cervical carcinoma cells of Cu(ii)/Zn(ii) complexes containing a carbohydrazone ligand.
    Parsekar SU; Velankanni P; Sridhar S; Haldar P; Mate NA; Banerjee A; Sudhadevi Antharjanam PK; Koley AP; Kumar M
    Dalton Trans; 2020 Mar; 49(9):2947-2965. PubMed ID: 32073070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dinuclear doubly bridged phenoxido copper(II) complexes as efficient anticancer agents.
    Massoud SS; Louka FR; Salem NMH; Fischer RC; Torvisco A; Mautner FA; Vančo J; Belza J; Dvořák Z; Trávníček Z
    Eur J Med Chem; 2023 Jan; 246():114992. PubMed ID: 36525695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sparfloxacin - Cu(II) - aromatic heterocyclic complexes: synthesis, characterization and
    Liu QY; Qi YY; Cai DH; Liu YJ; He L; Le XY
    Dalton Trans; 2022 Jun; 51(25):9878-9887. PubMed ID: 35713093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer.
    Iglesias S; Alvarez N; Torre MH; Kremer E; Ellena J; Ribeiro RR; Barroso RP; Costa-Filho AJ; Kramer MG; Facchin G
    J Inorg Biochem; 2014 Oct; 139():117-23. PubMed ID: 25033418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Water-soluble DNA minor groove binders as potential chemotherapeutic agents: synthesis, characterization, DNA binding and cleavage, antioxidation, cytotoxicity and HSA interactions.
    Fu XB; Liu DD; Lin Y; Hu W; Mao ZW; Le XY
    Dalton Trans; 2014 Jun; 43(23):8721-37. PubMed ID: 24770345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed ligand complexes of Co(II), Ni(II) and Cu(II) with quercetin and diimine ligands: synthesis, characterization, anti-cancer and anti-oxidant activity.
    Mutlu Gençkal H; Erkisa M; Alper P; Sahin S; Ulukaya E; Ari F
    J Biol Inorg Chem; 2020 Feb; 25(1):161-177. PubMed ID: 31832781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, and Biological Evaluation of Benzimidazole-Derived Biocompatible Copper(II) and Zinc(II) Complexes as Anticancer Chemotherapeutics.
    AlAjmi MF; Hussain A; Rehman MT; Khan AA; Shaikh PA; Khan RA
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.